欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号MT/H/0218/002
药品名称Caspofungin Mylan 70 mg powder for concentrate for solution
活性成分
    • Caspofungin acetate 70.0 mg
剂型Powder for concentrate for solution for infusion
上市许可持有人Mylan Pharmaceuticals Limited, Damastown Industrial Park, Mulhuddart, Dublin 15, Dublin, Ireland Mylan S.A.S (OLD MAH) 117, Allee des Parcs 69800 Saint Priest Franc
参考成员国 - 产品名称Malta (MT)
Caspofungin Alenicum 70 mg powder for concentrate for solution
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Sweden (SE)
    • Poland (PL)
      Caspofungin Mylan
    • Romania (RO)
    • Germany (DE)
      Caspofungin Mylan 70 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
    • Netherlands (NL)
      Caspofungine Alenicum 70 mg poeder voor concentraat voor oplossing voor infusie
许可日期2016/12/12
最近更新日期2025/06/12
药物ATC编码
    • J02AX04 caspofungin
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Multiple (Copy) Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase